Vital Signs to sell 1.8 million shares in follow on, secondary offering

New York, Dec. 23 - Vital Signs, Inc. said it plans to sell 1.8 million shares of common stock in a public offering, 434,000 shares to be sold by the company and 1.366 million by selling share holders.

J.P. Morgan Securities Inc. and Piper Jaffray & Co. are joint bookrunners for the registered sale. Thomas Weisel Partners LLC is co-manager.

There is a greenshoe for 270,000 shares to be offered by the selling shareholders.

The shareholders offering stock are two trusts established for the benefit of the children of Terry Wall, the company's president and chief executive officer, an estate planning trust called TW 2005 Trust established by Terry Wall and C. Barry Wicker, chief operating officer and executive vice president.

Vital Signs will use proceeds from the shares it is selling to finance possible acquisitions of complementary products, technologies or businesses and for working capital and other general corporate purposes. It will not receive proceeds from shares sold by shareholders.

The company is a Totowa, N.J., maker of single-use medical products for the anesthesia, respiratory/critical care and sleep/ventilation markets.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.